Drugs / Epo Beta
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00830609 Background | Nov 2008 → Sep 2011 | chronic hepatitis C virus infection | Dr. Conrado Fernandez | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epo Beta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00830609 ↗ |
| Route | Subcutaneous | “Epoetin β (450 IU/kg/week) SC” NCT00830609 ↗ |